Get the Stockscreener App
0.00
100.00%
-15.20
After Hours:
15.20
15.20
+
Euda Health Holdings Limited stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.
See More
Previous Close:
$15.20
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$45.51M
Revenue:
$2.81M
Net Income/Loss:
$-10.01M
P/E Ratio:
0.00
EPS:
-1.4846
Net Cash Flow:
$-1.30M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$15.95
52-Week Range:
$0.00
$86.00
Euda Health Holdings Limited Stock (EUDA) Company Profile
Name
Euda Health Holdings Limited
Sector
Industry
Phone
65 67880388
Address
1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN
Compare EUDA vs CBRE, BEKE, JLL, CSGP, COMP
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EUDA
Euda Health Holdings Limited
|
0.00 | 45.51M | 2.81M | -10.01M | -1.30M | -1.4846 |
CBRE
Cbre Group Inc
|
135.47 | 39.28B | 42.17B | 1.43B | 897.00M | 4.3837 |
BEKE
Ke Holdings Inc Adr
|
16.12 | 18.43B | 12.67B | 477.84M | 279.43M | 0.4156 |
JLL
Jones Lang Lasalle Inc
|
302.75 | 13.84B | 26.76B | 894.10M | 1.03B | 18.60 |
CSGP
Costar Group Inc
|
31.97 | 13.08B | 3.41B | 25.30M | 165.00M | 0.0602 |
COMP
Compass Inc
|
9.42 | 6.83B | 6.96B | -58.70M | 203.30M | -0.1082 |
Euda Health Holdings Limited Stock (EUDA) Latest News
EUDAW Drops 10% as Thin Trading Continues at $0.02 Support LevelSocial Sentiment - newsline.com
EUDAW Slides 5% to $0.02: Penny-Stock Warrant Tests Critical FloorStandard Deviation - newsline.com
EUDA Health (NASDAQ: EUDA) suspends ATM offering, files termination notice - Stock Titan
EUDA Health Halts and Moves to Terminate $10 Million ATM Equity Program - TipRanks
[6-K] EUDA Health Holdings Ltd Current Report (Foreign Issuer) - Stock Titan
Tan Meng Dong holds 15.3% of EUDA (NASDAQ: EUDA) in amended Schedule 13G - Stock Titan
Zhang Xin reports 295,000 shares in EUDA (EUDA) — 9.85% stake - Stock Titan
EUDA Health regains Nasdaq compliance after meeting minimum market value standards - MSN
EUDA Health Restores Nasdaq Compliance After Market Value Shortfall - The Globe and Mail
EUDA Health expands product line with new stem cell mask - Investing.com UK
EUDA Health (NASDAQ: EUDA) debuts Regenixé stem cell secretome mask - Stock Titan
EUDA Health (NASDAQ: EUDA) regains Nasdaq MVLS listing compliance - Stock Titan
EUDA Health regains Nasdaq listing compliance By Investing.com - Investing.com Australia
EUDA Health expands product line with new stem cell mask By Investing.com - Investing.com South Africa
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask - The Manila Times
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency - The Manila Times
EUDA Health Holdings Limited Regains Compliance with Nasdaq Listing Requirements - Quiver Quantitative
EUDA Health regains Nasdaq listing compliance - Investing.com
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell ... - Caledonian Record
Stem cell skincare: EUDA targets $8B face mask market with Regenixé - Stock Titan
EUDA Health restores Nasdaq listing compliance after value shortfall - Stock Titan
EUDA Health Holdings (EUDA) Slides 3.78% as Stock Tests Key Support LevelsGrowth ETF - newsline.com
EUDA Health Holdings Warrant (EUDAW) Holds at $0.03 Support After 3.79% DeclineMonthly Profile - newsline.com
EUDA Health Holdings (EUDA) Shows Minimal Movement as Shares Test Support ZoneFibonacci Arc - The Legal Advocate
EUDAEuda Health Holdings Limited Stock Price and Quote - Finviz
EUDA Health Holdings (EUDA) Rallies 3.69% as Buyers Step In Near SupportTriple Bottom - The Legal Advocate
EUDA Health (NASDAQ: EUDA) registers 947,963 shares for resale; MVLS notice - Stock Titan
EUDA Health Warrants (EUDAW) Hold Steady at $0.04 – Flat Session Highlights Lack of CatalystsStock News - The Legal Advocate
EUDAW Price History for Euda Health Holdings Ltd WT Stock - Barchart.com
Euda Health Holdings LimitedWarrant (NQ: EUDAW - FinancialContent
EUDA Stock Price, Quote & Chart | EUDA HEALTH HOLDINGS LTD (NASDAQ:EUDA) - ChartMill
Euda Health Holdings stock (US29821P1030): Trading at 14.40 USD with 4.65% gain - AD HOC NEWS
TradingKey - TradingKey
The fundamentals driving EUDA (EUDA) everyone should understand (+2.38%) 2026-05-08Trend Following Picks - The Legal Advocate
12 Health Care Stocks Moving In Wednesday's Intraday Session - Sahm
EUDAW (EUDA) management lays out core strategic growth priorities for 2024 following its latest quarterly earnings update.Community Watchlist - Newser
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
EUDA Health Showcases Shenzhen Inno’s Government-Backed TCR-T Cell Therapy Program - TipRanks
Going concern warning and heavy financing at EUDA (NASDAQ: EUDA) - Stock Titan
EUDA Health Warned by Nasdaq Over Market Value, Given Until October to Regain Compliance - The Globe and Mail
EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development - ChartMill
Euda Health Holdings Limited Stock (EUDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):